Comparison of Transversus Abdominis Plane Block and Ilioinguinal / Iliohypogastric Nerve Block
Brief Summary
Condition or Disease
- Intra-operative Anesthesia
Phase
Study Design
Study type: | INTERVENTIONAL |
---|---|
Status: | Unknown status |
Study results: | No Results Available |
Age: | 2 Years to 6 Years |
Enrollment: | 100 (ESTIMATED) |
Funded by: | Other |
Allocation: | Randomized |
Primary Purpose: | Supportive Care |
MaskingDOUBLE:
|
Clinical Trial Dates
Start date: | Dec 01, 2016 | |
---|---|---|
Primary Completion: | Aug 01, 2017 | ESTIMATED |
Completion Date: | Nov 01, 2017 | ESTIMATED |
Study First Posted: | Dec 13, 2016 | ESTIMATED |
Results First Posted: | Aug 31, 2020 | |
Last Updated: | Dec 08, 2016 |
Sponsors / Collaborators
Participant Groups
-
Transversus Abdominis Plane block after ketamine atropine induction and continued with ketamine only in anesthesia
-
After ketamine atropine induction, a laryngeal mask was inserted and anesthesia administration was continued with 2 sevoflurane minimum alveolar concentration and oxygen / air mixture and applied Transversus Abdominis Plane block.
-
Ilioinguinal / iliohypogastric block after ketamine atropine induction and continued with ketamine only in anesthesia
-
After ketamine atropine induction, a laryngeal mask was inserted and anesthesia administration was continued with 2 sevoflurane minimum alveolar concentration and oxygen / air mixture and applied Ilioinguinal / iliohypogastric block.
-
After ketamine atropine induction, a laryngeal mask was inserted and anesthesia administration was continued with 2 sevoflurane minimum alveolar concentration and oxygen / air mixture and Non-block, postoperative analgesia with paracetamol IV
Eligibility Criteria
Sex: | All |
---|---|
Minimum Age: | 2 |
Maximum Age: | 6 |
Age Groups: | Child |
Healthy Volunteers: | Yes |
* American society of anesthesia score I-II
* To undergo elective lower abdominal surgery
* between 2-6 years old
Exclusion Criteria:
* Patients with psychiatric disease
* Patients whose weight is more than 40 kg
* Patients with cardiac-pulmonary-neurological disease
* Patients with bleeding disorder
* Patients with infection or scar on the injection area
* Patients with known allergies to local anesthetics
Primary Outcomes
-
Amount of anesthetic drug which was used 2 hour
Secondary Outcomes
-
Postoperative visual analogue scale one day
More Details
NCT Number: | NCT02991053 |
---|---|
Other IDs: | ERZINCAN UNIVERSITY 8 |
Study URL: | https://clinicaltrials.gov/study/NCT02991053 |